跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
博珂 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Erdafitinib Tablets
Approved
化学药品
Erdafitinib Tablets
JANSSEN BIOTECH, INC.
🇨🇳 National Medical Products Administration
Approval Date
Jan 8, 2025
Approval ID
8gBdFCRUUYY
Company
JANSSEN BIOTECH, INC.
Type
化学药品
Approval Details
Approval Id
8gBdFCRUUYY
Approval Number
国药准字HJ20250009
Generic Name
厄达替尼片
Generic Name En
Erdafitinib Tablets
Trade Name
博珂
Drug Type
化学药品
Dosage Form
片剂
Strength
5mg
Reg Date
2025-01-08
Expired Date
2030-01-07
Company Name
JANSSEN BIOTECH, INC.
Production Company Name
Janssen-Cilag SpA
Company Detail Path
/organization/janssen-biotech-inc
Production Company Detail Path
/organization/janssen-cilag-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 8, 2025
Approval ID
8gBdFCRUUYY
Type
化学药品
Back to NMPA Approvals